| P50 | author | Paolo Calabresi | Q91934184 |
| P2093 | author name string | F Pisani | |
| | C Costa | |
| | D Caccamo | |
| | L R Pisani | |
| | P Mazzocchetti | |
| | R Ientile | |
| P2860 | cites work | Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders | Q21710687 |
| | Molecular targets for antiepileptic drug development | Q24683346 |
| | Cellular models to investigate biochemical pathways in Parkinson's disease | Q26829742 |
| | Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy | Q26849677 |
| | Epigenetic mechanisms of chronic pain | Q27023688 |
| | Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity | Q27024064 |
| | Animal models of traumatic brain injury | Q27025091 |
| | Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine | Q28269848 |
| | Oxidative stress in neurodegeneration: cause or consequence? | Q28275946 |
| | Animal models of ischemic stroke: balancing experimental aims and animal care | Q28296165 |
| | Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders | Q28384232 |
| | Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1 | Q28506681 |
| | The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion | Q28535091 |
| | Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia | Q44730698 |
| | Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction | Q44930696 |
| | Neuroprotective effects of topiramate | Q44971031 |
| | Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. | Q44989787 |
| | Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons | Q45004321 |
| | Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity | Q45305500 |
| | Transient cerebral ischemia increases CA1 pyramidal neuron excitability | Q45366999 |
| | Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons | Q28571794 |
| | Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation | Q28572236 |
| | Alzheimer's disease | Q29616743 |
| | Drug-mediated neuroprotection and antiepileptogenesis: animal data | Q30746341 |
| | Mood effects of antiepileptic drugs | Q30887496 |
| | The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance | Q33615756 |
| | A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures | Q34155061 |
| | Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. | Q34273047 |
| | Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. | Q34318938 |
| | Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives | Q34426072 |
| | Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research | Q34458158 |
| | Neuroprotection by valproic Acid in mouse models of permanent and transient focal cerebral ischemia | Q34554054 |
| | Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study | Q34573725 |
| | Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. | Q34627485 |
| | Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models | Q34768832 |
| | Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice | Q34771803 |
| | Experimental animal models of intracerebral hemorrhage | Q35027677 |
| | Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease | Q35106629 |
| | Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia | Q35143881 |
| | Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy | Q35172480 |
| | Neuroprotective effects of antiepileptic drugs. | Q35179272 |
| | Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. | Q35243356 |
| | Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease | Q35423803 |
| | Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). | Q35589934 |
| | Different effects of high- and low-dose phenobarbital on post-stroke seizure suppression and recovery in immature CD1 mice | Q35783263 |
| | Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! | Q35792838 |
| | Classic and new animal models of Parkinson's disease | Q35875871 |
| | Mechanisms of action of antiepileptic drugs. | Q36002922 |
| | Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update | Q36355248 |
| | Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke | Q36359744 |
| | Clinical pharmacology and mechanism of action of zonisamide | Q36924989 |
| | Protective effects of gabapentin on allodynia and alpha 2 delta 1-subunit of voltage-dependent calcium channel in spinal nerve-ligated rats | Q37116880 |
| | Phenytoin protects central axons in experimental autoimmune encephalomyelitis | Q37165887 |
| | Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions | Q37225136 |
| | Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. | Q46404080 |
| | Lamotrigine attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. | Q46740558 |
| | Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation | Q46894064 |
| | Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina | Q46898312 |
| | The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. | Q46958808 |
| | Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy | Q46980611 |
| | Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy | Q47795001 |
| | Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect | Q48123510 |
| | Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons | Q48193624 |
| | Neuroprotective effects of valproic acid against hemin toxicity: possible involvement of the down-regulation of heme oxygenase-1 by regulating ubiquitin-proteasomal pathway | Q48220909 |
| | Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. | Q48223619 |
| | Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. | Q48235397 |
| | Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease | Q48238293 |
| | Study of the protective effects of nootropic agents against neuronal damage induced by amyloid-beta (fragment 25-35) in cultured hippocampal neurons | Q48312003 |
| | Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model | Q48350023 |
| | Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage | Q48425824 |
| | In vitro oxygen-glucose deprivation to study ischemic cell death. | Q48445138 |
| | Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. | Q48473494 |
| | Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats | Q48473716 |
| | Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia | Q48598679 |
| | In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital | Q48650335 |
| | Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action | Q48710262 |
| | Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain | Q48721862 |
| | Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease | Q48773223 |
| | Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis | Q48837003 |
| | Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation | Q48858004 |
| | Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus | Q49050748 |
| | A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide | Q49057257 |
| | Effects of mood stabilizers on adult dentate gyrus-derived neural precursor cells | Q50441594 |
| | Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats. | Q50659873 |
| | Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation. | Q50685521 |
| | Valproic acid reduces neuritic plaque formation and improves learning deficits in APP(Swe) /PS1(A246E) transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin. | Q50706209 |
| | Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury. | Q50736416 |
| | Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. | Q52024302 |
| | Phenobarbital pre-treatment prevents kainic acid-induced impairments in acquisition learning. | Q52107500 |
| | Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. | Q52209617 |
| | Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells. | Q53130063 |
| | Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. | Q53574209 |
| | Antioxidant, anticonvulsive and neuroprotective effects of dapsone and phenobarbital against kainic acid-induced damage in rats. | Q53789683 |
| | Felbamate neuroprotection against CA1 traumatic neuronal injury | Q71377077 |
| | Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia | Q73489981 |
| | Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue | Q74149576 |
| | Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine | Q80678677 |
| | Lamotrigine increases the number of BrdU-labeled cells in the rat hippocampus | Q82850870 |
| | Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats | Q83830542 |
| | Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors | Q84279124 |
| | Prospects of levetiracetam as a neuroprotective drug against status epilepticus, traumatic brain injury, and stroke | Q37276387 |
| | The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain | Q37304728 |
| | Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity | Q37341162 |
| | Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease | Q37356891 |
| | Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells | Q37610451 |
| | Redox homeostasis and cellular stress response in aging and neurodegeneration | Q37655706 |
| | Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy | Q37772663 |
| | Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases | Q37983057 |
| | Establishment of experimental models for Alzheimer's disease research | Q38106507 |
| | Post-treatment with voltage-gated Na(+) channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons | Q38275406 |
| | Animal models of Parkinson's disease: An updated overview. | Q38581837 |
| | What is hormesis and its relevance to healthy aging and longevity? | Q38582970 |
| | Zonisamide suppresses endoplasmic reticulum stress-induced neuronal cell damage in vitro and in vivo | Q38952930 |
| | Protective effects of zonisamide against rotenone-induced neurotoxicity | Q39076196 |
| | Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways | Q39571186 |
| | Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. | Q39858360 |
| | Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models | Q39924456 |
| | Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. | Q40232814 |
| | Zonisamide inhibits nitric oxide synthase activity induced by N-methyl-D-aspartate and buthionine sulfoximine in the rat hippocampus. | Q41740998 |
| | Electrophysiological actions of felbamate on rat striatal neurones. | Q42177610 |
| | Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition | Q42439876 |
| | The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1β and TNF-α expression in rat hippocampus | Q42460187 |
| | Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. | Q42463079 |
| | Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. | Q42480993 |
| | Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study | Q42546501 |
| | Phenobarbital augments hypothermic neuroprotection. | Q42725654 |
| | Zonisamide attenuates MPTP neurotoxicity in marmosets | Q42858552 |
| | Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process | Q42862763 |
| | Zonisamide reduces cell death in SH-SY5Y cells via an anti-apoptotic effect and by upregulating MnSOD. | Q42988173 |
| | Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice | Q43083221 |
| | Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease. | Q43288037 |
| | Protective effect of carbamazepine on kainic acid-induced neuronal cell death through activation of signal transducer and activator of transcription-3. | Q43439841 |
| | Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina | Q43649930 |
| | Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction | Q43779242 |
| | Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). | Q44154771 |
| | Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis | Q44190587 |
| | Polytherapy in epilepsy: the experimental evidence | Q44225576 |
| | Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation | Q44280661 |
| | Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic mice | Q44301949 |
| | Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies | Q44332173 |
| | Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. | Q44535353 |
| | Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy | Q44639225 |
| | Levetiracetam protects against kainic acid-induced toxicity | Q44707450 |
| P433 | issue | 1-2 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 340-352 | |
| P577 | publication date | 2015-12-31 | |
| P1433 | published in | Neurochemical Research | Q15716728 |
| P1476 | title | Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs | |
| P478 | volume | 41 | |